Analytical Data
-
基因名
U100
- Application
-
别名
U100；
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9QJ11
-
表达区间
25-354aa
-
氨基酸序列
TVHRDAGTVESTPPPDDEDNYTAKYYDDSIYFNIYDGTNPTPRRRTLPEIISKFSTSEMSRLGGLKAFVPVDYTPTTTLEDIEDLLNYAICDDNSCGCLIETEARSMFGDIIICVPLSAESRGVRNLKSRIMPMGLSQILSSGLGLHFSLLYGAFGSNYNSLAYMERLKPLTAMTAIAFCPMTSKLELRQNYRLEKARSNLIVNIELLKIQNHGGQTIKTLTSFAIVRKDSDGQDWETCTRFASVSIEDILRSKPAANGTCCPPRDVHHDRPTLQSSNSWTRTEYFEPWQDVVDAYVPINDNHCPNDSYVVFQTLQGHEWCSRLNKNDTK
-
分子量
44.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The U100 recombinant protein has emerged as a focal point in biotechnology and pharmaceutical research due to its potential applications in various fields, including therapeutics, diagnostics, and vaccine development. Recent advancements in protein engineering and expression systems have enabled the efficient production of U100, a protein characterized by its unique structure and functional properties. Researchers are particularly interested in its role in modulating immune responses and its potential as a drug target for diseases such as cancer and autoimmune disorders. The ability to produce U100 in recombinant systems allows for high yields and purity, making it suitable for further studies. Investigations into its stability, activity, and interactions within biological systems are crucial for understanding its mechanisms and potential applications. As interest in personalized medicine grows, U100 could play a pivotal role in the development of targeted therapies, offering hope for improved patient outcomes. Ongoing research aims to unveil the full spectrum of U100's biological functions and its implications in health and disease, driving innovation in treatment strategies and contributing to the broader field of protein-based therapeutics.
